Metraipolis › archive › dc_69fb26cf3215
Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS) — Europe PMC PMID:41964289
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41964289
- DOI
- 10.1155/prm/8822463
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:31:11.776Z
- SHA-256 of the archived text
9b30e182bdb2e176465161f9f88ceacfa24dedbf6333ff6b8c90a5dce1724555- Stable URL of this page
https://metraipolis.com/documento/dc_69fb26cf3215
How to cite
Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS) — Europe PMC PMID:41964289 — Europe PMC (en), https://europepmc.org/article/MED/41964289 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_69fb26cf3215 (Metraipolis archive dc_69fb26cf3215, sha256 9b30e182bdb2e176465161f9f88ceacfa24dedbf6333ff6b8c90a5dce1724555)
BibTeX
@misc{dc69fb26cf3215,
title = {Indications and Adverse Events of Toradol: Based on FDA Adverse Event Reporting System (FAERS) — Europe PMC PMID:41964289},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41964289},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_69fb26cf3215; sha256 9b30e182bdb2e176465161f9f88ceacfa24dedbf6333ff6b8c90a5dce1724555},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41964289. Agents can read the archived copy with the MCP tool read_document.